Long-term treatment with pravastatin reduces coronary heart disease mortality in women with prior coronary heart disease and average cholesterol levels

被引:0
|
作者
Hague, W
Johns, J
Young, P
Hunt, D
Bradfield, R
Denton, M
Garrett, J
Aylward, P
Tonkin, A
Simes, J
机构
[1] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia
[2] Natl Heart Fdn Australia, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:262A / 262A
页数:1
相关论文
共 50 条
  • [1] Pravastatin reduces total mortality in patients with coronary heart disease and average cholesterol levels: Relationship of baseline cholesterol and treatment effects in the LIPID trial
    Simes, RJ
    Baker, J
    MacMahon, S
    Hague, W
    Colquhoun, D
    West, M
    Arulchelvam, M
    Shaw, J
    Tonkin, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 281A - 281A
  • [2] Cost-effectiveness of pravastatin in patients with coronary heart disease and average cholesterol levels
    Glasziou, PP
    Mulray, SE
    Hall, JP
    Martin, A
    Harris, P
    Thompson, P
    Tonkin, A
    Simes, RJ
    [J]. MEDICAL DECISION MAKING, 1998, 18 (04) : 475 - 475
  • [3] Adiponectin levels and long-term mortality in coronary heart disease patients and controls
    Hascoet, S.
    Bongard, V.
    Ferrieres, J.
    Perret, B.
    Galinier, M.
    Carrie, D.
    Elbaz, M.
    Ruidavets, J. B.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 813 - 813
  • [4] Pravastatin reduces mortality in patients with a broad range of lipid levels with or without prior coronary heart disease: The prospective pravastatin pooling project
    Simes, RJ
    Braunwald, E
    Shepherd, J
    Craven, T
    Davis, BR
    Furberg, C
    [J]. CIRCULATION, 1999, 100 (18) : 825 - 825
  • [5] Pravastatin and coronary heart disease
    Bloom, JM
    [J]. LANCET, 2001, 357 (9261): : 1040 - 1040
  • [6] Pravastatin and coronary heart disease
    Assmann, G
    Schulte, H
    Cullen, P
    [J]. CIRCULATION, 1998, 98 (25) : 2933 - 2934
  • [7] Pravastatin and coronary heart disease
    Meyer, FP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (14): : 1115 - 1116
  • [8] Prevention of mortality from coronary heart disease with pravastatin
    Tonkin, AM
    Ryan, EW
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (09) : 405 - 408
  • [9] Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up
    Simes, RJ
    Hunt, D
    Kirby, A
    Tonkin, A
    Keech, A
    Aylward, P
    Colquhoun, D
    Glasziou, P
    Hague, W
    MacMahon, S
    Thompson, P
    West, M
    White, H
    Tonkin, A
    Avlward, P
    Colquhoun, D
    Glasziou, P
    Harris, P
    Hunt, D
    Keech, A
    McMahon, S
    Sharpe, N
    Simes, RJ
    Thompson, P
    Thomson, A
    West, M
    White, H
    [J]. LANCET, 2002, 359 (9315): : 1379 - 1387
  • [10] Prevalence of depression is not increased by long-term pravastatin therapy in patients with coronary heart disease
    Weyers, J
    Colquhoun, D
    Stewart, R
    Tonkin, A
    Kirby, A
    White, H
    Simes, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 268A - 268A